期刊文献+

脑膜瘤尾征组织侵袭与病理分型、免疫组化、MRI表现相关性研究 被引量:1

下载PDF
导出
摘要 目的:探讨凸面脑膜瘤尾征组织肿瘤细胞侵袭与病理分型、免疫组化、MR I表现相关性,以拟定最佳手术方案。方法:选取具有脑膜尾征的凸面脑膜瘤54例,手术中切除瘤体及脑膜尾征对应组织,送病理检查、免疫组化,将脑膜尾征组织侵袭与肿瘤病理分型、免疫组化、MR I表现进行统计学分析。结果:54例凸面脑膜瘤患者中,22例病理提示肿瘤细胞侵袭脑膜尾征对应组织,占40.74%,脑膜尾征侵蚀组与未侵蚀组与瘤周水肿、尾征形态、瘤内囊性变有显著性差异,而与病理级别、免疫组化、肿瘤部位、大小、形态无明显相关性。结论:具有脑膜尾征的凸面脑膜瘤患者,对于瘤周水肿明显、瘤内存在囊性变及尾征形态不规则串珠样者,术中应尽多切除尾征对应组织,以降低复发。
出处 《赣南医学院学报》 2011年第3期352-354,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
  • 相关文献

参考文献7

  • 1Mirimanoff RO,Dosomtz DE,Linggccd RM,et al. Meningio- ma: analysis of recurrence and progression following neuro- surgical resection[ J]. J Neurosurg,1985,62(1) :18-24.
  • 2Kawahara Y, Niilro M, Yokoyama S, et al. Dural congestion accompanying meningioma invasion into vessels:the dural tail sig[ J ]. Neuromdiology ,2001,43 (6) :462-465.
  • 3唐晓平,刘琬椿,余定庸,漆建,唐文国,罗仁国.脑膜瘤术后复发因素的回顾性分析[J].中国临床神经外科杂志,2004,9(4):310-311. 被引量:10
  • 4Ayerbe J, Lobato RD. Risk factors predicting recurrence in patients operated On for intracranical meningioma. A mult-iVariate analysis [ J ]. Acta Neurochi ( wein), 1999, 141 (9) :921-932.
  • 5Mende RE, Lath B, Delgado MR, et al. predieding the probability of Meningioma recurrence base on te quantity of" peritumeral brain edema on computerized tomograpiy scanning[ J]. 1 Neurosury, 1999,91:375-383.
  • 6张建国,赵洪洋.预测脑膜瘤复发的相关因素研究[J].国外医学(神经病学.神经外科学分册),2002,29(5):403-406. 被引量:3
  • 7Ahmadi J, liintoa DR, SegaU HD, et al. surgical implica- tions of magnetic resonance-enhanced dura[J].Neurosur- gery, 1994,35 (3) :370-377.

二级参考文献28

  • 1李龄,王承缘.突面脑膜瘤合并硬脑膜“尾”征的手术意义[J].中华神经外科杂志,1997,13(3):147-149. 被引量:14
  • 2Ayerbe J,Lobato RD,de la cruz J,et al.Risk factors predicting recurrence in patients operated on for intracranial meningioma.A multivariate analysis [J].Acta Neurochir (Wien),1999,141(9):921~932.
  • 3Smith HP,chalia VR,Moody DM,et al.Biological features of meningiomas that determine the production of cerebral edema [J].Neurosurgery,1981,4(2):428~433.
  • 4Nakabayashi H,Sakaguchi M,Katsu-yama J,et al.Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression [J].J Neurooncol,1995,24:209~217.
  • 5Simpson D.The recurrence of intracranial meningiomas after surgical treatment [J].J Neurol Neurosurg psychiatry,1957,20:22~25.
  • 6Ayerbe J, Lobato RD, de la cruz J, et al. Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir(Wien), 1999,141(9): 921-932.
  • 7Vagner- Capodano AM, Grisoli F, Gambarelli D, et al. Correlation between cytogenetic and histopathological findings in 75 human meningiomas. Neurosurgery, 1993, 32(6): 892-900.
  • 8Mantle RE, Lach B, Delgado MR, et al. Predictingj the probability of mertingioma recurrence based on the quantity of peritumoral brain edema on computeried tomography scanning. J Neuresurg, 1999, 91 (3): 375-383.
  • 9Chen TC. Zee CS. Miller CA , et al. Magnetic resonance imaging and pathological correlates of meningiomas. Neuresurgery, 1992, 31 (6): 1015-1021.
  • 10Palma L, Celli P, Franco C, et al, Longterm prognosis for atypical and malignant maningiomas: a study of 71 surgical series. J Neurosurg, 1997, 86(5): 793-800.

共引文献11

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部